Uses of Amipace 100mg Tablet
Amipace 100mg Tablet is used for the treatment or prevention of the following disease(s):
Arrhythmias
Side effects of Amipace 100mg Tablet
Precautions while taking Amipace 100mg Tablet
Dosage of Amipace 100mg Tablet
Overdose of Amipace 100mg Tablet
Onset of Action of Amipace 100mg Tablet
Duration of Action of Amipace 100mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Amipace 100mg Tablet
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
anticoagulants: Increased anticoagulant response and possibly serious bleeding azole antifungals, fluoroquinolones, macrolide.
antibiotics: Increased risk of prolonged QT interval and life-threatening arrhythmias.
beta blockers: Increased serum levels of beta blockers with increased risk of AV block, hypotension, and bradycardia.
calcium channel blockers: Increased serum levels of these drugs and increased risk of AV block, bradycardia, and hypotension cholestyramine, phenytoin, rifampin, St.
John's wort: Decreased amiodarone level.
cimetidine: Increased amiodarone level.
clopidogrel: Increased risk of ineffective inhibition of platelet aggregation.
cyclosporine: Increased cyclosporine level dextromethorphan, methotrexate,
phenytoin: Increased serum levels of these drugs and increased risk of toxicity if amiodarone is taken orally for more than 2 weeks.
digoxin: Increased serum digoxin level and risk of digitalis toxicity diltiazem, propranolol, verapamil: Increased risk of hemodynamic and electrophysiologic abnormalities
disopyramide: Increased serum disopyramide level with QT prolongation and increased risk of arrhythmias.
fentanyl: Increased serum fentanyl level with increased risk of bradycardia, decreased cardiac output, and hypotension.
flecainide: Increased serum flecainide level.
HMG-CoA reductase inhibitors such as atorvastatin and simvastatin: Increased risk of myopathy and rhabdomyolysis.
hydantoins: Increased serum hydantoin level with long-term use and reduced serum amiodarone level.
lidocaine: Increased serum lidocaine level and risk of seizures and bradycardia loratadine,
trazodone: Increased risk of QTinterval prolongation and torsades de pointes.
potassium- and magnesium-depleting drugs: Increased risk of hypokalemia and hypomagnesemia.
procainamide: Increased serum procainamide or N-acetylprocainamide.
levelquinidine: Increased serum quinidine level with risk of life-threatening arrhythmias.
ritonavir: Increased serum amiodarone level with increased risk of cardiotoxicity.
theophylline: Increased serum theophylline level, increased risk of theophylline toxicity.
warfarin: Increased PT and risk of bleeding.
Food :-
grapefruit juice: Increased amiodarone level.